Document is current
Any future updates will be listed below
-
Authors
Mizuno, Seiko https://orcid.org/0009-0002-7301-2144
Minatoya, Machiko https://orcid.org/0000-0002-1306-3073
Osaga, Satoshi https://orcid.org/0000-0003-4459-2469
Chin, Rina https://orcid.org/0000-0001-5578-7814
Imori, Makoto
-
Funding
Funding for this research was provided by:
Eli Lilly Japan
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 21 October 2024
First Online: 21 November 2024
Declarations
:
: All authors (Seiko Mizuno, Machiko Minatoya, Satoshi Osaga, Rina Chin, Makoto Imori) are employees of Eli Lilly Japan K.K. and are minor stockholders of Eli Lilly and Company.
: This study was conducted in accordance with ethical principles originating from the Declaration of Helsinki of 1964 and its later amendments and that were consistent with Good Pharmacoepidemiology Practices. This study used retrospective de-identified data so ethical review and informed consent were not required, consistent with the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects. Data were purchased from MDV after obtaining the necessary permissions.
